-
1 Comment
Beijing Aosaikang Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 8.0% below its 200 day moving average.
From a valuation standpoint, the stock is 26.9% cheaper than other stocks from the Industrials sector with a price to sales ratio of 3.7.
Beijing Aosaikang Pharmaceutical Co., Ltd's total revenue rose by 23.3% to $1B since the same quarter in the previous year.
Its net income has increased by 29.0% to $251M since the same quarter in the previous year.
Finally, its free cash flow grew by 600.0% to $192M since the same quarter in the previous year.
Based on the above factors, Beijing Aosaikang Pharmaceutical Co., Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| ISIN | CNE100001X92 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| CurrencyCode | CNY |
| Beta | 0.13 |
|---|---|
| Market Cap | 12B |
| Dividend Yield | 0.8% |
| Target Price | 23 |
| PE Ratio | 46.14 |
Beijing Aosaikang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of active pharmaceutical ingredients and formulations in China. It also offers digestive health products, which include pump inhibitors suitable for various digestive tract-related diseases, such as peptic ulcers, reflux esophagitis, and upper gastrointestinal bleeding; and anti-tumor products, including the treatment of non-small cell lung cancer, colorectal cancer, and breast cancer, encompassing targeted therapy, chemotherapy, endocrine therapy, and adjuvant medications. In addition, the company provides anti-infective products comprising a product defense line against bacterial and invasive fungal infections; and the chronic disease field focusing on chronic diseases requiring long-term management consisting of diabetes, osteoarthritis, thrombocytopenia, and iron overload. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 1996 and is based in Nanjing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002755.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
